(Reuters) – The U.S. Food and Drug Administration said on Monday that it had approved Otsuka Pharmaceutical Co Ltd’s Abilify MyCite, the first drug with a digital ingestion tracking system to be approved in the United States.

https://www.reuters.com/article/us-otsuka-holdings-fda/fda-approves-first-drug-in-u-s-with-digital-ingestion-tracking-idUSKBN1DE039